| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |